Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin to Prevent Prostate Cancer
NCT02757365Phase 4Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2014
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in prostate cancer (PCa) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: prostate specific antigen at 3 months, digital rectal examination at 3 months and 3 more. Status: unknown.
02
Drugs
aspirin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02757365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757365.